Alzheimer's disease trials recruiting in Ohio
All Alzheimer's disease trials nationally
27
Recruiting in Ohio
13
Cities with sites
Cities in Ohio
Columbus 11Dayton 7Independence 5Beachwood 4Cleveland 3Blue Ash 2Centerville 2North Canton 2Athens 1Canton 1Cincinnati 1Lima 1
Recruiting trials in Ohio
- A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
- A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
- A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
- A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
- ACP-204 in Adults With Alzheimer's Disease Psychosis
- Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
- Delirium Identification in Older Patients With Alzheimer's and Other Related Dementias In the Emergency Department
- Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
- Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
- Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
- Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
- Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Trial-Ready Cohort-Down Syndrome (TRC-DS)
- [18F]PI-2620 Phase 3 Histopathological Study